University of Vienna, UZA2
Vienna University of Technology
Medical University of Vienna
Institute of Science and Technology
MolTag 2
MolTag 2

Ion channels and transporters as drug targets

"Ion channels and transporters as molecular drug targets" (MolTag) is a PhD/doctoral program in pharmaceutical sciences established at the University of Vienna, the Medical University of Vienna, the Vienna University of Technology and the recently added Institute of Science and Technology Austria at Klosterneuburg. The graduate program is financed by a research grant of the Austrian Science Fund (FWF). MolTag offers a broad three-year PhD education in pharmaceutical sciences including specialized field courses such as molecular pharmacology, pharmacoinformatics, structure-function analysis of target molecules, biophysics, imaging and advanced synthetic chemistry. Applicants at MolTag have completed a diploma study in medicine or a high quality master program in natural sciences, such as pharmacy, biology, molecular biology or chemistry. MolTag provides comprehensive training in relevant research areas of pharmaceutical research, with focus on drug discovery and drug development. MolTag will provide PhD students with contacts to national and international research labs, including the pharmaceutical industry. We aim to create an atmosphere of collaborative and interdisciplinary research.

Latest News

Since 2011, MolTag students of the first and second funding period produced more than 100 publications (with 44 first-authorships). Since 2015, already 30 of them (11 as first-author) resulted from participation of MolTag2 students, - and the trend continues! Check out our publication record so far!

Congrats to MolTag-Faculty Member Nuno Maulide: The Austrian Academy of Sciences (OeAW) elected Nuno as member of the Young Academy. Read more.
Comprised of excellent junior researchers from all disciplines, the Young Academy also strengthens innovative research, optimizes research conditions, promotes young scientists and has comprehensive participation rights.

Congrats! MolTag associate Felix Mayer, PhD student at Medical University of Vienna, has finished his doctoral thesis (Supervisor: Harald Sitte) and defended with distinction on April 20th, 2017.


Guest Lecture by Hugo R. ARIAS, California Northstate University, "Functional and structural studies on positive allosteric Modulators of α7 nicotinic receptors", takes place June 7th, 05:00 pm, at UZA 2, SE Room 2D 313, invitaton and abstract is available here.

Guest Lecture by Laura CONFORTI, University of Cincinnati, "Potassium channels in T lymphocytes as therapeutic targets in cancer", takes place June 26th, 05:00 pm, at UZA 2, SE Room 2D 358, invitation and abstract is available here.

The 2-day-MolTag Retreat 2017 will take place (again) in Strass im Strassertal. We expect Chris Ahern, University of Iowa, for a Key Note Lecture. Program for MolTag members is available soon.